Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
8.03
-0.35 (-4.18%)
At close: Oct 23, 2026, 4:00 PM EDT
8.02
-0.01 (-0.12%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $614.44 million as of October 23, 2026. It is the 13,124th most valuable company in the world and the 2,585th biggest in the United States. Its market cap has increased by 112.80% in one year.
Market Cap
614.44M
Enterprise Value
462.40M
1-Year Change
112.80%
Global Rank
Country Rank
#2,585 United States
Category
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $614.44M, an increase of 176.29%. That is a compound annual growth rate of 21.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 614.44M | 98.10% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 669.93M |
| Achieve Life Sciences | 667.84M |
| Attovia Therapeutics | 665.14M |
| Solid Biosciences | 663.72M |
| Prime Medicine | 663.58M |
| Wave Life Sciences | 663.07M |
| Ginkgo Bioworks Holdings | 657.58M |
| Design Therapeutics | 657.11M |